Company description

RIEMSER Pharma GmbH is a speciality pharmaceutical company established in December 1992 with core competencies focused on targeting therapy areas with high unmet medical needs. RIEMSER markets its own product portfolio in numerous therapeutical areas including oncology, neurology, antiinfectives and dermatology. RIEMSER’s success is attributed to the effective acquisition and licensing of products adding significant value to its distribution channels which spans over 60 countries with more than 300 approvals worldwide. As a result of the extensive experience and vast market knowledge, Riemser has successfully submitted and received 30 approvals over the past two years.With strategic acquisitions in Europe, RIEMSER has progressively enhanced its expertise and competencies in the core markets.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Finished Dosage Forms More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 120G78 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 42A03 See our Exhibitor Profile   See full Exhibitor List

Our Top products

RIEMER PHARMA Product list

RIEMER PHARMA Product list

RIEMER PHARMA Product list

More info

News about RIEMSER Pharma GmbH

Introducing RIEMSER Pharma GmbH

10 Jul 2019

Introducing RIEMSER Pharma GmbH

Riemser Pharma GmbH was established in 1992 and emerged from the Friedrich Löffler Institute on Riems Island (Greifswald).

Read more

Categories affiliated with RIEMSER Pharma GmbH


Contact information




View all contact information